In summary, the deactivation of the Stat3-Bcl-2 pathway contributes to metformin-induced growth inhibition of ESCC by facilitating crosstalk between apoptosis and autophagy [54,55]. This evidence concerns the gene STAT3 and esophageal squamous cell carcinoma.